Clinical characteristics and management of patients with ST segment elevation myocardial infarction in China: Survey of 7510 cases

National Medical Journal of China

Volumn 85, Issue 31, 2005, Pages 2176-2182

  Yang, Yang Min ^a   Zhu, Jun ^a   Tan, Hui Qiong ^a   Liang, Yan ^a   Zhang, Yan ^a   Li, Jian Dong ^a   Liu, Li Sheng ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Baseline characteristics; Clinical protocols; Infarction; Myocardial

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

ADULT; ARTICLE; CHINA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DATA ANALYSIS; DIABETES MELLITUS; DRUG COST; DRUG USE; FIBRINOLYTIC THERAPY; HEALTH CARE FACILITY; HEALTH SURVEY; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; ONSET AGE; PERCUTANEOUS CORONARY INTERVENTION; REGISTER; ST SEGMENT ELEVATION; STROKE; SYMPTOMATOLOGY; TREATMENT PLANNING;

ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CHINA; ELECTROCARDIOGRAPHY; FEMALE; HEPARIN; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; URINARY PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 23844525855     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. ISIS-2 (Second International Study of Infarct Survival) Collaborative group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infaretion: ISIS 2. Lancet, 1988, 1: 349-360.
2. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet, 1994, 343: 311-322.
3. ISIS-1 (first international study of infarct survival) Collaborative Group. randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet, 1996, 2: 57-66.
4. ISIS-4 (fourth international study of infarct survival) Collaborative Group. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet, 1995, 345: 669-685.
5. Chang WC, Fu Y, Ohman EM, et al. Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from Canada and the United States. the north american GUSTO-I and GUSTO-III investigators. Can J Cardiol, 2000, 16: 1231-1239.
6. Chen YD, Song XT, Lü SZ, et al. Evaluation of varions therapies in patients with acute ST segment elevation myocardial infarction who arrived at hospitals within 12 hours from the onset of chest pain. Chin J Intervent Cardiol, 2005, 13: 5-8.
7. Tan HQ, Zhu J, Liang Y, et al. Two year follow-up of acute ischemic syndrome without ST elevation. Natl Med J China, 2005, 85: 184-188.
8. Liang Y, Zhu J, Tan HQ, et al. The influencing factors of surviving time of patients with non-ST elevation acute coronary syndromes in China. Natl Med J China, 2005, 85: 873-877.
9. Philippe GS, Robert JG, Joel MG, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardial, 2002, 90: 358-363.
10. Ribichini F, Ferrero V, Wijns W. Reperfusion treatment of ST-elevation acute myocardial infarction. Prog Cardiovasc Dis, 2004, 47: 131-157.
11. Eagle KA, Goodman SG, Avezum A, et al. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the global registry of acute coronary events (GRACE). Lancet, 2002, 359: 373-377.
12. Hasdai D, Topol EJ, Kilaru R, et al. Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from international fibrinolytic therapy trials. Am Heart J, 2003, 145: 73-79.